Lipotecan
TLC388A1008
Phase 2 small_molecule terminated
Quick answer
Lipotecan for HepatoCellular Carcinoma is a Phase 2 program (small_molecule) at Taiwan Liposome Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiwan Liposome Company
- Indication
- HepatoCellular Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated